Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Late annual account NBB
Fiscal year 2024 was filed 230 days after the legal deadline.
Financials
Financial year 2024
Pharmacies et Gestion de Pharmacies from Sint-Jans-Molenbeek, company number BE0430296255, closed financial year 2024 with a result of € 35,314 after tax. For that financial year Pharmacies et Gestion de Pharmacies recorded a gross margin of € 287,743 and equity of € 673,249. Compared with financial year 2023, the result moved from € 52,084 to € 35,314. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 16, 2025.
€ 673,249
▲ 6% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 35,314
▼ 32% vs 2023
Profit after tax over the fiscal year.
€ 77,174
▼ 53% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 610,036.
People and assets in 2024
4
Average over the fiscal year, from the social balance sheet.
€ 139,002
▼ 6% vs 2023
€ 34,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 448,175
▼ 9% vs 2023
Of which on lease € 446,949.
Debts at end 2024
€ 357,182
▼ 16% vs 2023
€ 64,359 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 319,961
▲ 9% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 70,829
▼ 7% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Revenue | € 1,432,696 | - | € 2,743,265 | - | |
| Gross margin | € 240,788 | € 272,046 | € 308,549 | € 287,743 | ▼ 7% |
| Profit after taxes | € 20,407 | € 28,547 | € 52,084 | € 35,314 | ▼ 32% |
| Equity | € 582,306 | € 610,852 | € 637,936 | € 673,249 | ▲ 6% |
| Total debts | € 795,796 | € 824,495 | € 821,754 | € 768,761 | ▼ 6% |
| Cash | € 3,146 | € 42,391 | € 164,248 | € 77,174 | ▼ 53% |
| Retained profit | € 519,093 | € 547,639 | € 574,723 | € 610,036 | ▲ 6% |
| Dividend | € 0 | € 0 | € 25,000 | € 0 | ▼ 100% |
| Bank debt | € 527,635 | € 474,356 | € 424,213 | € 357,182 | ▼ 16% |
| Balance sheet total | € 1,378,101 | € 1,435,347 | € 1,459,689 | € 1,442,011 | ▼ 1% |
| Employees (FTE) | 5 | 5 | - | 4 |
Key figures of Pharmacies et Gestion de Pharmacies, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 April 2026.
What happened to Pharmacies et Gestion de Pharmacies?
What happened at Pharmacies et Gestion de Pharmacies in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 35,314 (▼ 32% vs 2023). filed late Source: NBB ↗
- PHARMACIE ET GESTION DE PHARMACIE PHARMACIE ET GESTION DE PHARMACIE became a director. NBB
- New establishment in Sint-Jans-Molenbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 20,407 profit in 2021 to € 35,314 profit in 2024.
Paid € 90,629 in corporate taxes since 2021.
Best year ever: 2023, with € 52,084 profit.
On average € 71,900 of value added per employee in 2024.
A new publication or filing at Pharmacies et Gestion de Pharmacies? We notify you, reason included.
Follow Pharmacies et Gestion de PharmaciesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharmacies et Gestion de Pharmacies is PHARMACIE ET GESTION DE PHARMACIE PHARMACIE ET GESTION DE PHARMACIE.
Directors
According to the 2024 annual accounts
PHARMACIE ET GESTION DE PHARMACIE PHARMACIE ET GESTION DE PHARMACIE
Director
since 2020
Establishments
Establishment units
Physical locations of this company
de Ribaucourtstraat 122
1080 Sint-Jans-Molenbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0430.296.255
- VAT number
- BE 0430.296.255
- Registered office
- de Ribaucourtstraat 122, 1080 Sint-Jans-Molenbeek
- Names & denominations
- Pharmacies et Gestion de Pharmacies · Pharma-Gesphar
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 January 1987
- Peppol
- Active · Active since 4 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers